| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing prilocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Prilocaine poisoning |
Causative agent |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Accidental prilocaine poisoning (disorder) |
Causative agent |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| Intentional prilocaine poisoning |
Causative agent |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| forgiftning med prilocain, uvist med hvilken hensigt |
Causative agent |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Prilocaine adverse reaction |
Causative agent |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to prilocaine (finding) |
Causative agent |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| Prilocaine overdose |
Causative agent |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Accidental prilocaine overdose |
Causative agent |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Intentional prilocaine overdose |
Causative agent |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| overdosis af prilocain, uvist med hvilken hensigt |
Causative agent |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine+prilocaine 2.5%/2.5% cream+occlusive dressing |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| Product containing lidocaine and prilocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing felypressin and prilocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| prilocainhydrochlorid 3 % + felypressin 0,03 enheder, dental type, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| prilocainhydrochlorid 3 % + felypressin 0,06 enheder/2 ml, selvaspirerende cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| prilocainhydrochlorid 4 %/adrenalin 200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| adrenalin 5 µg + prilocainhydrochlorid 40 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine + prilocaine 25mg/25mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| Prilocaine hydrochloride (substance) |
Is a |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| prilocainhydrochlorid 4 % injektionsvæske, opløsning, hætteglas a 1,8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| lidocain 2,5 %/prilocain 2,5 % periodontalgel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| Accidental prilocaine poisoning (disorder) |
Causative agent |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Intentional prilocaine poisoning |
Causative agent |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to prilocaine (finding) |
Causative agent |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Prilocaine hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prilocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing lidocaine and prilocaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Prilocaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing felypressin and prilocaine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Felypressin and prilocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine and prilocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Prilocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine and prilocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only prilocaine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Felypressin and prilocaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine and prilocaine only product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline- and prilocaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline- and prilocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing lidocaine and prilocaine in dental dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline and prilocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline and prilocaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine (substance) |
Inferred relationship |
Some |
1 |
FHIR